| abstract |
The present disclosure provides imaging agents and methods for imaging surface cell receptors, particularly CXCR4 receptors and biological conditions associated with the expression of CXCR4 receptors, including, but not limited to, cancer and metastasis. In embodiments, the present disclosure provides radiolabeled CXCR4 peptide antagonists detectable in vivo or in vitro by a PET scanner. |